162 related articles for article (PubMed ID: 12034694)
1. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy.
Goldberg I
Br J Ophthalmol; 2002 Jun; 86(6):691-2. PubMed ID: 12034694
[No Abstract] [Full Text] [Related]
2. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 1.
Anton A
Br J Ophthalmol; 2002 Jun; 86(6):692-3; discussion 695. PubMed ID: 12075596
[No Abstract] [Full Text] [Related]
3. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 2.
Skuta GL
Br J Ophthalmol; 2002 Jun; 86(6):693-4; discussion 695. PubMed ID: 12075597
[No Abstract] [Full Text] [Related]
4. The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis.
Kocabeyoglu S; Mocan MC; Irkec M
Acta Ophthalmol; 2014 Nov; 92(7):e592-3. PubMed ID: 24774884
[No Abstract] [Full Text] [Related]
5. Systemic β-Blockers Do Not Affect Glaucoma Eye Drop Effectiveness.
Johnson TV; Jampel HD
Ophthalmology; 2021 Feb; 128(2):326-328. PubMed ID: 32622847
[No Abstract] [Full Text] [Related]
6. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
7. One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Fukushima A; Suganami H; Araie M;
Acta Ophthalmol; 2016 Feb; 94(1):e26-34. PubMed ID: 26338317
[TBL] [Abstract][Full Text] [Related]
8. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
Simmons ST; Earl ML;
Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
[TBL] [Abstract][Full Text] [Related]
9. The role of beta blockers in open angle glaucoma.
Marmion VJ
Indian J Ophthalmol; 1982 Jul; 30(4):229-31. PubMed ID: 6131867
[No Abstract] [Full Text] [Related]
10. Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association.
Italian Multicentric Open Randomized Study under the aegis of A.I.S.G.: Final Results and Official Report
Acta Ophthalmol Scand Suppl; 2000; (232):49-50. PubMed ID: 11235535
[No Abstract] [Full Text] [Related]
11. Beta adrenergic blocking agents for open-angle glaucoma.
Lee ME
J Am Optom Assoc; 1988 Jul; 59(7):567-71. PubMed ID: 2900260
[TBL] [Abstract][Full Text] [Related]
12. Initial medical management of open-angle glaucoma.
Fechtner RD
J Glaucoma; 2000 Feb; 9(1):83-6. PubMed ID: 10708236
[No Abstract] [Full Text] [Related]
13. The role of medical therapy in the rank order of glaucoma treatment.
Wilensky JT
Curr Opin Ophthalmol; 1999 Apr; 10(2):109-11. PubMed ID: 10537759
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers in the treatment of chronic simple glaucoma.
Hitchings RA
Br Med J (Clin Res Ed); 1982 Jul; 285(6335):84-5. PubMed ID: 6123368
[No Abstract] [Full Text] [Related]
15. Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.
Pillunat LE; Larsson LI;
Br J Ophthalmol; 2003 Dec; 87(12):1492-6. PubMed ID: 14660460
[TBL] [Abstract][Full Text] [Related]
16. Studies of monocular trials of glaucoma medications: conflicting results explained by varying methods.
Leffler CT
Arch Ophthalmol; 2009 May; 127(5):707-8; author reply 708. PubMed ID: 19433731
[No Abstract] [Full Text] [Related]
17. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
Tugushi OA; Shliapuzhnikova AV; Listopadova NA
Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
[No Abstract] [Full Text] [Related]
18. Topical beta-blockers are not associated with an increased risk of treatment for depression.
Kaiserman I; Kaiserman N; Elhayany A; Vinker S
Ophthalmology; 2006 Jul; 113(7):1077-80. PubMed ID: 16815397
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertension.
Quinones R; Earl ML
Adv Ther; 2004; 21(6):370-9. PubMed ID: 15856860
[TBL] [Abstract][Full Text] [Related]
20. Topical beta blockers in asthmatic patients-is it safe?
Kaiserman I; Fendyur A; Vinker S
Curr Eye Res; 2009 Jul; 34(7):517-22. PubMed ID: 19899964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
